Insys: Will The Drug Pipeline Drive Growth?
March 12, 2018 at 06:11 AM EDT
INSY's Q4 revenue declined over 40% Y/Y, but was up 3% sequentially. Revenue declines appear to have subsided. Its $163MM of cash and investments could support the company until its drug pipeline kicks in.
